Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Johnson & Johnson Halts Development of Flu Treatment Candidate
By Tony Owusu
Sep 2, 2020 11:48 AM EDT
PRESS RELEASES
ALERT: Halper Sadeh LLP Is Investigating The Following Mergers; Shareholders Are Encouraged To Contact The Firm
By PR Newswire
Sep 17, 2020 4:31 PM EDT
PRESS RELEASES
Momenta Pharmaceuticals Announces Expiration Of Hart-Scott-Rodino Waiting Period In Connection With Proposed Sale To Johnson & Johnson
By GlobeNewswire
Sep 15, 2020 8:00 AM EDT
INVESTING
Johnson & Johnson Halts Development of Flu Treatment Candidate
By Tony Owusu
Sep 2, 2020 11:48 AM EDT
PRESS RELEASES
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates The Following Mergers; Shareholders Are Encouraged To Contact The Firm - MVC, PRNB, YIN, MNTA
By PR Newswire
Aug 22, 2020 5:00 AM EDT
INVESTING
Johnson & Johnson Sets Late-Stage Vaccine Trial Next Month
By Rob Lenihan
Aug 20, 2020 3:35 PM EDT
PRESS RELEASES
Moore Kuehn Encourages NTN, PRNB, MNTA, And PFNX Investors To Contact Law Firm
By PR Newswire
Aug 20, 2020 1:44 PM EDT
PRESS RELEASES
MOMENTA INVESTOR ALERT By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy Of Price And Process In Proposed Sale Of Momenta Pharmaceuticals, Inc. - MNTA
By Business Wire
Aug 20, 2020 11:42 AM EDT
PRESS RELEASES
SHAREHOLDER ALERT: WeissLaw LLP Investigates Momenta Pharmaceuticals, Inc.
By PR Newswire
Aug 19, 2020 6:35 PM EDT
PRESS RELEASES
INVESTOR ALERT: Monteverde & Associates PC Announces An Investigation Of Momenta Pharmaceuticals, Inc. - MNTA
By PR Newswire
Aug 19, 2020 2:20 PM EDT
INVESTING
Could Momenta Deal Give Johnson & Johnson Breakout Momentum?
By Bret Kenwell
Aug 19, 2020 1:05 PM EDT
PRESS RELEASES
MOMENTA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale Of MNTA And Encourages Investors To Contact The Firm
By Business Wire
Aug 19, 2020 12:52 PM EDT
Video
Johnson & Johnson Gains Drugmaker Momenta in $6.5B Deal
Aug 19, 2020 9:55 AM EDT
PRESS RELEASES
(MNTA) Alert: Johnson Fistel Investigates Proposed Sale Of Momenta Pharmaceuticals; Are Shareholders Getting A Fair Price?
By PR Newswire
Aug 19, 2020 7:38 AM EDT
MERGERS AND ACQUISITIONS
Johnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 Billion
By M. Corey Goldman
Aug 19, 2020 9:57 AM EDT
PRESS RELEASES
Momenta Pharmaceuticals Announces Date Of Second Quarter 2020 Financial Results Conference Call And Webcast
By GlobeNewswire
Aug 3, 2020 7:30 AM EDT
PRESS RELEASES
Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation For Nipocalimab In HDFN
By GlobeNewswire
Jul 28, 2020 7:15 AM EDT
PRESS RELEASES
Momenta Pharmaceuticals Announces Positive Topline Data From Interim Analysis Of Phase 2 Vivacity-MG Study Of Nipocalimab (M281) In Generalized Myasthenia Gravis (gMG)
By GlobeNewswire
Jun 15, 2020 7:05 AM EDT
PRESS RELEASES
Momenta Pharmaceuticals Announces Date Of First Quarter 2020 Financial Results Conference Call And Webcast
By GlobeNewswire
Apr 23, 2020 8:00 AM EDT
PRESS RELEASES
Momenta Provides Corporate Update Amid COVID-19 Pandemic
By GlobeNewswire
Apr 2, 2020 7:30 AM EDT
PRESS RELEASES
Momenta Pharmaceuticals To Webcast Presentation At The Cowen 40th Annual Health Care Conference
By GlobeNewswire
Feb 19, 2020 8:00 AM EST
PRESS RELEASES
Momenta Pharmaceuticals Announces Date Of Fourth Quarter And Year End 2019 Financial Results Conference Call And Webcast
By GlobeNewswire
Feb 12, 2020 8:00 AM EST
INVESTING
Momenta Rockets After Analysts Get Bullish on Biopharma's Newest Treatment
By Scott Van Voorhis
Jan 15, 2020 11:08 AM EST
STOCKS
Teva shares fall as FDA OKs another generic version of multiple sclerosis drug
By Armie Margaret Lee
Feb 13, 2018 5:33 PM EST
STOCKS
States Target Mylan President, Emcure Exec in Generic Drug Lawsuit
By Armie Margaret Lee
Nov 1, 2017 4:59 PM EDT